Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Primary IgG4-related lymphadenopathy with prominent granulomatous inflammation and reactivation of Epstein–Barr virus

Abstract

We report a unique case of primary IgG4-related lymphadenopathy showing prominent granulomatous inflammation and Epstein–Barr virus (EBV) reactivation. Involved lymph nodes showed an expanded interfollicular zone with prominent granulomatous inflammation, including a predominance of epithelioid macrophages and occasional Langhans multinucleated giant cells. Bundles of spindle cells were also observed. Intermingled with the granulomatous inflammation were numerous mature plasma cells, eosinophils, and neutrophils. The percentage of IgG4+/IgG+ plasma cells was markedly elevated (70%), along with raised serum IgG4 levels. The plasma cells did not show immunoglobulin light-chain restriction. EBV-positive lymphocytes were scattered throughout the paracortical areas. Corticosteroid treatment was very effective. IgG4-related lymphadenopathy has a broad histological spectrum and might be misdiagnosed due to other conditions which morphologically closely resemble it. The correct diagnosis is important in view of the remarkable response to steroid therapy.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 60:247–258

  2. 2.

    Cheuk W, Yuen HKL, Chu SYY, Shiu EKW, Lam LK, Chan JKC (2008) Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 32:671–681

  3. 3.

    Cheuk W, Chan JKC (2010) IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 17:303–332

  4. 4.

    Kojima M, Miyazaki S, Takada S, Kashiwabara K, Igarashi T, Nakamura S (2008) Lymphoplasmacytic infiltrate of regional lymph nodes in Küttner’s tumor (chronic sclerosing sialadenitis): a report of 3 cases. Int J Surg Pathol 16:263–268

  5. 5.

    Armed forces institute of Pathology (2009) Granulomatous inflammation. In: O’malley DP, George TL, Orazi A, Abbondanzo SI (eds) Benign and reactive conditions of lymph node and spleen. American Registry of Pathology, Washington, pp 119–125

  6. 6.

    Kojima M, Nakamura S, Shimizu K, Hosomura Y, Ohno Y, Itoh H, Yamane N, Yoshida K, Masawa N (2001) Inflammatory pseudotumor of lymph nodes: clinicopathological study of 11 Japanese cases. Int J Surg Pathol 9:207–214

  7. 7.

    Moran CA, Suster S, Abbondanzo SL (1996) Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity. Hum Pathol 28:332–338

  8. 8.

    Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H (1992) Patterns of Epstein–Barr virus infection in Non-neoplastic lymphoid tissue. Blood 79:2520–2526

  9. 9.

    Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726–4735

Download references

Acknowledgments

The authors acknowledge the technical assistance of Kaneko Sakurai, Eriko Wada, Mitsunori Sato, Junji Sano, and Yoshimi Mizuno.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Correspondence to Emiko Takahashi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Takahashi, E., Kojima, M., Kobayashi, M. et al. Primary IgG4-related lymphadenopathy with prominent granulomatous inflammation and reactivation of Epstein–Barr virus. Virchows Arch 460, 225–229 (2012). https://doi.org/10.1007/s00428-011-1186-7

Download citation

Keywords

  • IgG4-related lymphadenopathy
  • IgG4-related disease
  • Granulomatous inflammation
  • Epstein−Barr virus
  • Reactivation of Epstein−Barr virus